François B, Garcia Sanchez M, Eggimann P, et al. Suvratoxumab reduces staphylococcus aureus pneumonia in high-risk icu patients: results of the SAATELLITE Study. Am J Resp Crit Care Med. 2019;199:A7358.
Prognose van asymptomatische en symptomatische ongediagnosticeerde COPD in Denemarken
jun 2017 | COPD